Corbus Pharmaceuticals Beats Estimates For Fourth Quarter

CANNANNEW REPORT

Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP)  reported financial results for the fourth quarter and year-end 2020.… Read More….. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Corbus Pharmaceuticals Beats Estimates For Fourth Quarter

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.